LRBa1709/2
MPG/JK:wlj:jf
September 2011 Special Session
2011 - 2012 LEGISLATURE
ASSEMBLY AMENDMENT 1,
TO ASSEMBLY BILL 21
October 24, 2011 - Offered by Representative Marklein.
AB21-AA1,1,11 At the locations indicated, amend the bill as follows:
AB21-AA1,1,2 21. Page 7, line 17: substitute "2013-14" for "2012-13".
AB21-AA1,1,3 32. Page 7, line 19: substitute "2014-15" for "2013-14".
AB21-AA1,1,4 43. Page 7, line 21: substitute "2015-16" for "2014-15".
AB21-AA1,1,5 54. Page 7, line 23: substitute "2016-17" for "2015-16".
AB21-AA1,1,6 65. Page 7, line 24: after that line insert:
AB21-AA1,1,9 7"(r) Additional operational or administrative expenses. From the Wisconsin
8next generation reserve fund, a sum sufficient equal to any amount authorized under
9s. 555.06 for general program operations and administrative expenses.".
AB21-AA1,1,11 106. Page 10, line 1: delete lines 1 and 2 and substitute "qualifying companies
11for calendar year 2011.".
AB21-AA1,2,3
17. Page 10, line 3: delete the material beginning with "in" and ending with
2"2012" on line 4 and substitute "on July 1, 2013, and on each July 1 thereafter, ending
3on July 1, 2026".
AB21-AA1,2,4 48. Page 10, line 7: delete "that fiscal" and substitute "the previous calendar".
AB21-AA1,2,6 59. Page 10, line 7: delete the material beginning with "(a). The" and ending
6with "companies" on line 9 and substitute "(a)".
AB21-AA1,2,8 710. Page 10, line 15: delete the material beginning with "The" and ending with
8"2026." on line 16.
AB21-AA1,2,9 911. Page 13, line 18: after that line insert:
AB21-AA1,2,12 10"555.05 Annual report. Annually, the board shall submit to the chief clerk
11of each house of the legislature, for distribution to the legislature under s. 13.172 (2),
12a report that includes all of the following:
AB21-AA1,2,13 13(1) An accounting of the revenue received in the fund under s. 73.16 (2).
AB21-AA1,2,15 14(2) An accounting of all expenditures from the fund by the board for any
15purpose.
AB21-AA1,2,17 16(3) For each each certified bioscience company that received a grant, loan, or
17investment from the board during the preceding year, all of the following:
AB21-AA1,2,1818 (a) The name and address of the certified bioscience company.
AB21-AA1,2,2019 (b) A description of the nature of the business conducted by the certified
20bioscience company.
AB21-AA1,2,2121 (c) The amount of the grant, loan, or investment.
AB21-AA1,2,2322 (d) A description of the purposes for which the certified bioscience company
23used or is using the grant, loan, or investment.
AB21-AA1,3,2
1(4) An accounting of the internal rate of return realized by the board on its
2loans to and investments in certified bioscience companies.
AB21-AA1,3,18 3555.06 Expenditure of fund moneys for operational or administrative
4costs.
If the board determines that the amount provided under s. 20.195 (1) (q) 1.,
52., 3., or 4. is not sufficient to cover the board's actual general program operations and
6administrative expenses for a fiscal year, the board may notify the joint committee
7on finance in writing that the board proposes to exceed that amount for those
8purposes. That notice shall state the specific amount of additional moneys from the
9fund that the board proposes to use for general program operations and
10administrative expenses and the board's reasons supporting its determination that
11its expenditure of that additional amount is necessary for those purposes. If, within
1214 working days after the date of that notice, the cochairpersons of the committee do
13not notify the board that the committee has scheduled a meeting to review the board's
14proposal, the board may expend the additional amount as proposed in the board's
15notice. If, within 14 working days after the date of that notice, the cochairpersons
16of the committee notify the board that the committee has scheduled a meeting to
17review the board's proposal, the board may expend the additional amount only upon
18approval of the committee.".
AB21-AA1,3,1919 (End)
Loading...
Loading...